PDL BioPharma, Inc. Long Term Debt (Total)

Long Term Debt (Total) of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long Term Debt (Total) growth rates and interactive chart. Long-term debt is debt that matures in more than one year. The sum of long-term bank loans, debentures or bonds outstanding. Refers to interest-bearing debt. An indebted company pays interest on its debt, which is recorded on the income statement and reduces net income to common shareholders. Long-term debt is used in ratios lke Debt/Equity or Debt/Assets to determine the financial health of a business.


Highlights and Quick Summary

  • Long Term Debt (Total) for the quarter ending June 29, 2020 was $13.5 Million (a 1.54% increase compared to previous quarter)
  • Year-over-year quarterly Long Term Debt (Total) decreased by -89.8%
  • Annual Long Term Debt (Total) for 2019 was $27.3 Million (a -78.14% decrease from previous year)
  • Annual Long Term Debt (Total) for 2018 was $125 Million (a 6.16% increase from previous year)
  • Annual Long Term Debt (Total) for 2017 was $117 Million (a -49.49% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long Term Debt (Total) of PDL BioPharma, Inc.

Most recent Long Term Debt (Total)of PDLI including historical data for past 10 years.

Interactive Chart of Long Term Debt (Total) of PDL BioPharma, Inc.

PDL BioPharma, Inc. Long Term Debt (Total) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $13.51 $13.3
2019 $27.25 $132.48 $128.52 $126.57 $27.25
2018 $124.64 $122.78 $120.95 $119.17 $124.64
2017 $117.42 $115.72 $114.04 $112.43 $117.42
2016 $232.44 $234.9 $232.85 $230.85 $232.44
2015 $228.86 $281.58 $279.75 $277.98 $228.86
2014 $276.23 $274.51 $272.82 $270.94 $276.23
2013 $147.02 $145.8 $312.61
2012 $309.95 $307.34 $304.77 $302.24 $309.95
2011 $316.62 $315.37 $332.6 $243.42 $316.62
2010 $395.45 $340.61 $388.09 $395.45

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.